Sidra Medicine signs MoU with Microsoft to achieve digital transformation goals in research 25 October 2022, Doha, Qatar – Sidra Medicine has signed a memorandum of understanding (MoU) with Microsoft to facilitate its research division’s digital transformation goals and accelerate its precis… Continue Reading.....

Sidra Medicine launches Menopause Clinic QF Entity coincides new service opening with World Menopause Day 18 October 2022, Doha, Qatar – Sidra Medicine has launched a new Menopause Clinic, a comprehensive service dedicated to the manageme… Continue Reading.....

Sidra Medicine to host Women’s Health Conference QF Entity to focus on women’s wellness within a holistic context 4 October 2022, Doha, Qatar – Sidra Medicine will virtually host a Women’s Health Conference (WHC 2022) from 14-15 October 2022. The… Continue Reading.....

Sidra Medicine Precision Medicine Functional Genomics Symposium Major Success 29 September 2022, Doha, Qatar – Sidra Medicine successfully concluded its Precision Medicine Functional Genomics symposium (PMFG 2022) to a packed audience of over 640 registered attendees during the… Continue Reading.....

Sidra Medicine Publishes Groundbreaking study on Pediatric Cancer Tumors QF Entity study highlights precision medicine approach to guide treatment for certain childhood cancers 21 September 2022, Doha, Qatar – Researchers from Human Immunology in collaboration with the … Continue Reading.....

Sidra Medicine Gene Therapy Program Saves Lives QF Entity Appointed as Lead Treatment Center in MENA to administer life-saving SMA drug for babies 14 September 2022, Doha, Qatar – The Genetics and Genomic division at Sidra Medicine has launched … Continue Reading.....